Carregant...
New insights into acquired endocrine resistance of breast cancer
The translational research strategy of targeting estrogen receptor α (ERα) positive breast cancer and then using long term anti-hormone adjuvant therapy (5-10 years) has reduced recurrences and mortality. However, resistance continues to occur and improvements are required to build on the success of...
Guardat en:
| Publicat a: | Cancer Drug Resist |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
OAE Publishing Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897388/ https://ncbi.nlm.nih.gov/pubmed/31815253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.13 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|